ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response
Descrição
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://journals.sagepub.com/cms/10.1177/1203475418824565/asset/images/large/10.1177_1203475418824565-fig2.jpeg)
Treating to Target(s) With Interleukin-17 Inhibitors - Charles W. Lynde, Jennifer Beecker, Jan Dutz, Cathy Flanagan, Lyn C. Guenther, Wayne Gulliver, Kim Papp, Proton Rahman, Dalton Sholter, Gordon E. Searles, 2019
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://www.researchgate.net/publication/362316830/figure/fig3/AS:1183078147997697@1659079219552/Changes-from-baseline-in-ASDAS-and-BASFI-over-time-Dashed-line-all-patients-randomised.jpg)
Changes from baseline in ASDAS and BASFI over time. Dashed line: all
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://www.rinvoqhcp.com/content/dam/rinvoqhcp/images/ankylosing-spondylitis/joint-efficacy/SELECT-AXIS2Study1_AS.png)
Disease Control Data, Ankylosing Spondylitis
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://www.researchgate.net/publication/351383140/figure/tbl1/AS:1024176089464834@1621194016717/Baseline-characteristics-of-patients-included-in-the-two-treatment-arms_Q320.jpg)
Baseline characteristics of patients included in the two treatment arms
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-020-00269-6/MediaObjects/40744_2020_269_Fig3_HTML.png)
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://d3i71xaburhd42.cloudfront.net/040a8eae9e50b086f19688c7317472bbff973f6d/6-Figure3-1.png)
PDF] ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://europepmc.org/articles/PMC9606523/bin/ard-2022-222608f04.jpg)
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. - Abstract - Europe PMC
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://acrabstracts.org/wp-content/uploads/2021/09/ACR_1063180_1.jpg)
Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://www.dovepress.com/getfile_article_fulltext.php?filename=article_fulltext%2Fs330000%2F330413/img/DDDT_A_330413_O_F0002g.jpg)
Management of axial spondyloarthritis
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-020-00269-6/MediaObjects/40744_2020_269_Fig1_HTML.png)
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://www.simponiariahcp.com/sites/www.simponiariahcp-v1.com/files/48-perc.png)
SIMPONI ARIA® Ankylosing Spondylitis: ASAS Response Rates
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-019-0165-3/MediaObjects/40744_2019_165_Fig1_HTML.png)
Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis
![ASAS-HI improvement ≥30%, ASDAS LDA status and ASAS40 response](https://onlinelibrary.wiley.com/cms/asset/98fcd7c8-fd99-40b8-9d56-42145ba119d4/imj.v50.s2.cover.jpg?trick=1697199561421)
ARA Abstracts - 2020 - Internal Medicine Journal - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)